Persson K, Pandita R K, Spitsbergen J M, Steers W D, Tuttle J B, Andersson K E
Department of Clinical Pharmacology, Lund University Hospital, S-221 85 Lund, Sweden.
Am J Physiol. 1998 Oct;275(4):R1366-73. doi: 10.1152/ajpregu.1998.275.4.R1366.
The influence of noradrenergic mechanisms involved in micturition in spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats was investigated using continuous cystometry in in vivo and in vitro studies on isolated bladder and urethral tissues. Compared with WKY rats, SHR had a significantly lower bladder capacity (SHR: 0.7 +/- 0. 05 ml; WKY rats: 1.3 +/- 0.06 ml; P < 0.001), micturition volume (SHR: 0.4 +/- 0.04 ml, WKY rats: 1.2 +/- 0.05 ml; P < 0.001), and an increased amplitude of nonvoiding (unstable) bladder contractions. The effects of intrathecal and intra-arterial doxazosin on cystometric parameters were more pronounced in SHR than in WKY rats. There was a marked reduction in nonvoiding contractions after intrathecal (but not intra-arterial) doxazosin in SHR. Norepinephrine (0.1 microM-1 mM) failed to evoke contractions in bladder strips from WKY rats, in contrast to a weak contractile response in SHR. The response to electrical field stimulation was significantly less in bladder strips from SHR than from WKY rats. In WKY rats, norepinephrine produced concentration-dependent inhibition (87 +/- 5%, n = 6) of nerve-evoked bladder contractions. Almost no inhibition (11 +/- 8%, n = 6) was found in SHR. Alterations in bladder function of SHR appear to be associated with changes in the noradrenergic control of the micturition reflex, in addition to an increased smooth muscle and decreased neuronal responsiveness to norepinephrine. The marked reduction in nonvoiding contractions after intrathecal doxazosin suggests that the bladder hyperactivity in SHR has at least part of its origin in supraspinal and/or spinal structures.
通过对自发性高血压大鼠(SHR)和Wistar-Kyoto(WKY)大鼠进行体内连续膀胱测压以及对分离的膀胱和尿道组织进行体外研究,探讨了参与排尿的去甲肾上腺素能机制的影响。与WKY大鼠相比,SHR的膀胱容量显著降低(SHR:0.7±0.05 ml;WKY大鼠:1.3±0.06 ml;P<0.001),排尿量减少(SHR:0.4±0.04 ml,WKY大鼠:1.2±0.05 ml;P<0.001),并且非排尿(不稳定)膀胱收缩的幅度增加。鞘内和动脉内给予多沙唑嗪对膀胱测压参数的影响在SHR中比在WKY大鼠中更明显。鞘内(而非动脉内)给予多沙唑嗪后,SHR的非排尿收缩明显减少。去甲肾上腺素(0.1μM - 1 mM)未能引起WKY大鼠膀胱条带收缩,而SHR则有较弱的收缩反应。SHR膀胱条带对电场刺激的反应明显低于WKY大鼠。在WKY大鼠中,去甲肾上腺素产生浓度依赖性抑制(87±5%,n = 6)神经诱发的膀胱收缩。在SHR中几乎未发现抑制作用(11±8%,n = 6)。SHR膀胱功能的改变似乎与排尿反射的去甲肾上腺素能控制变化有关,此外平滑肌增加以及神经元对去甲肾上腺素的反应性降低。鞘内给予多沙唑嗪后非排尿收缩明显减少表明,SHR的膀胱活动亢进至少部分源于脊髓上和/或脊髓结构。